Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

2 Feb 2012 07:00

RNS Number : 6452W
Avon Rubber PLC
02 February 2012
 



Strictly embargoed until 07:00 Thursday 2 February 2012

 

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 OCTOBER 2011 TO 1 FEBRUARY 2012

Protection & Defence

In Protection & Defence we have orders in hand from the US Department of Defense (DoD) which will allow us to deliver higher volumes of the M50 respirator in our 2012 financial year. On 20 December 2011 we announced the award of a five year contract for the M61 filter evaluated at $176m, including an initial order worth $2.5m for immediate delivery. One of the losing bidders has raised a contractual protest to the DoD, which will delay delivery dates for this order, although our expectations of deliveries for the full year remain unchanged. Deliveries against our $6.1m filter order, placed under a separate three year contract and announced at the same time, areunaffected.

 

The pipeline of sales opportunities remains strong in our non-DoD markets, albeit in the current economic and political environment the exact timing of the receipt of orders is difficult to predict.

 

Our new program of product range expansion and enhancement (Project Fusion), which is expected to provide further organic growth from 2013, has commenced and is progressing to plan.

 

Dairy

In Dairy strong market conditions prevail and we have seen further growth in sales of our Milk-Rite brand, in particular the Impulse Mouthpiece Vented Liner (IP-MV) which achieved a 10% market share in North America, offsetting weaker demand from some of our OE customers. We have also opened a sales and distribution centre in China to further capitalise on the extensive opportunity in that region.

 

Net debt

The Group's balance sheet remains robust with net debt at 31 December 2011 at £7.0m (30 September 2011: £11.8m) due to the timing of working capital movements. Net debt is expected to increase by half year due to the working capital required to fulfil the filter orders as well as further acceleration in our programme of investment in product development.

 

Outlook

The Board believes that the financial year will deliver further progress although, as last year, the timing of filter deliveries is likely to result in a greater second half year weighting.

 

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896831

Andrew Lewis, Group Finance Director

01225 896830

Miles Ingrey-Counter, Company Secretary

01225 896850

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological,Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder,

emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced

CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised

solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and

tubing for the automated milking process. For further information please visit the Group's website www.avon‐rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSDFWFFESELE
Date   Source Headline
15th May 20251:00 pmRNSHolding(s) in Company
7th May 202510:00 amRNSDirectors'/PDMR Shareholding
6th May 202512:00 pmRNS-RNotice of Results & Investor Presentation via IMC
11th Apr 20254:00 pmRNSHolding(s) in Company
8th Apr 202511:00 amRNSDirectors'/PDMR Shareholding
27th Mar 20252:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSQ2 trading update
20th Mar 202510:00 amRNSHolding(s) in Company
11th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20253:00 pmRNSDirectors'/PDMR Shareholdings
4th Mar 20254:00 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNext Generation IHPS Delivery Order
14th Feb 20252:00 pmRNSDirectors'/PDMR Shareholding
11th Feb 20254:00 pmRNSHolding(s) in Company
7th Feb 20254:00 pmRNSFinal Dividend Currency Exchange Rate
5th Feb 20254:00 pmRNSDirectors'/PDMR Shareholdings
31st Jan 202512:00 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement
27th Jan 20253:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNSThales UK Contract Renewal
7th Jan 20259:00 amRNSDirectors'/PDMR Shareholding
6th Jan 20257:00 amRNSNext Generation IHPS Delivery Order
12th Dec 20242:00 pmRNSHolding in Company
10th Dec 20249:00 amRNSNotice of Annual Report & Accounts and AGM 2025
6th Dec 202411:00 amRNSDirectors'/PDMR Shareholding
28th Nov 20245:00 pmRNSDirector/PDMR Shareholding
19th Nov 20242:00 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
6th Nov 20242:00 pmRNSHolding in Company
6th Nov 202410:00 amRNSDirectors'/PDMR Shareholding
25th Oct 202411:05 amRNSAppointment of Joint Corporate Broker
22nd Oct 20247:00 amRNSNotice of Results
8th Oct 202410:00 amRNSDirectors'/PDMR Shareholding
2nd Oct 20243:05 pmRNSHolding(s) in Company
26th Sep 20246:05 pmRNSHolding(s) in Company
10th Sep 20243:30 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSInterim Dividend Currency Exchange Rate
7th Aug 20249:00 amRNSDirectors'/PDMR Shareholdings
1st Aug 20248:19 amRNSChange of Company Name
1st Aug 20247:00 amRNSHolding(s) in Company
29th Jul 202412:00 pmRNSPDMR Shareholdings
25th Jul 20247:00 amRNSNew delivery order & updated FY 2024 guidance
10th Jul 20249:00 amRNSNotification of transaction of PDMR
8th Jul 202412:00 pmRNSDirectors'/PDMR Shareholdings
6th Jun 20243:00 pmRNSDirectors'/PDMR Shareholdings
30th May 20245:00 pmRNSHolding(s) in Company
28th May 20245:00 pmRNSHolding(s) in Company
24th May 20244:00 pmRNSHolding(s) in Company
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.